Reinsurance Group (RGA) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Reinsurance Group (RGA) reported Q2 2025 revenue of $5.64 billion, a 9.6% year-over-year increase, but missed the Zacks consensus estimate of $5.71 billion. EPS declined to $4.72 from $5.48 a year ago, also falling short of the $5.58 consensus. The earnings miss was notably impacted by a significant negative variance in U.S. and Latin America Financial Solutions net premiums, despite robust net investment income. Shares have underperformed the S&P 500 over the past month, reflecting these mixed results and consensus misses.

Analysis

Reinsurance Group (RGA) reported mixed Q2 2025 results, characterized by top-line growth that failed to meet expectations and a significant year-over-year decline in earnings per share. While revenue increased 9.6% YoY to $5.64 billion, it fell 1.09% short of the $5.71 billion consensus estimate. The earnings picture was more concerning, with EPS declining to $4.72 from $5.48 in the prior-year period, missing the $5.58 analyst estimate by a substantial 15.41%. A deeper look at the metrics reveals the primary source of weakness was the U.S. and Latin America Financial Solutions segment, which reported negative net premiums of $5 million, a stark contrast to the expected $245.13 million. This shortfall, along with a net investment-related loss of $44 million against an expected gain and a 42.9% YoY drop in 'Other revenues', overshadowed positive performance elsewhere. Notably, the company's overall net investment income was a bright spot, coming in at $1.41 billion and decisively beating the $1.22 billion consensus. The market has priced in this disappointment, with RGA's shares returning -2.9% over the past month, underperforming the S&P 500 composite's +2.7% gain.

Key Decisions for Investors

• Investors should scrutinize management's explanation for the severe negative variance in the U.S. and Latin America Financial Solutions' net premiums to determine if this is a one-time issue or a systemic problem.
• The significant outperformance in net investment income should be weighed against the weakness in core underwriting results and the 42.9% YoY decline in 'Other revenues' to form a balanced view of the company's operational health.
• Given the stock's recent underperformance and the neutral Zacks Rank #3 (Hold), a wait-and-see approach may be prudent until there is more clarity on the drivers behind the earnings miss.
• The swing from an expected investment-related gain to a $44 million loss introduces a new risk factor, warranting closer monitoring of the company's investment portfolio volatility in future reports.